Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-09

FDA Approved: LEVORA — Supplemental Application (Mayne Pharma Inc.)

View source ↗

Summary

FDA supplemental application approval for LEVORA (levonorgestrel and ethinyl estradiol) submitted by Mayne Pharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVORA (levonorgestrel and ethinyl estradiol)

Snippet

SUPPL AP for LEVORA (LEVONORGESTREL AND ETHINYL ESTRADIOL)